All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
ICPT / Intercept Pharmaceuticals Inc Put
|
|
|
|
|
|
|
|
STRM / Streamline Health Solutions, Inc.
|
|
|
|
|
|
|
|
LRMR / Larimar Therapeutics, Inc.
|
|
|
|
|
|
|
|
YMTX / Yumanity Therapeutics Inc
|
|
|
|
|
|
|
|
ITCI / Intra-Cellular Therapies, Inc. Put
|
|
|
|
|
|
|
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
BOLD / Boundless Bio, Inc.
|
|
|
|
|
|
|
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
/ Array BioPharma, Inc. Call
|
|
|
|
|
|
|
|
DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
FOMX / Foamix Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
EPZM / Epizyme Inc
|
|
|
|
|
|
|
|
KRYS / Krystal Biotech, Inc.
|
|
|
|
|
|
|
|
ONCE / Spark Therapeutics, Inc.
|
|
|
|
|
|
|
|
US00163U1060 / AMAG Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
OSMT / Osmotica Pharmaceuticals Plc
|
|
|
|
|
|
|
|
ARGX / argenx SE - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
GNFT / Genfit S.A.
|
|
|
|
|
|
|
|
BHVN / Biohaven Ltd. Put
|
|
|
|
|
|
|
|
FGEN / FibroGen, Inc. Put
|
|
|
|
|
|
|
|
XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
DERM / Journey Medical Corporation Put
|
|
|
|
|
|
|
|
VIRX / Viracta Therapeutics, Inc.
|
|
|
|
|
|
|
|
ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
US60877T1007 / Momenta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
TPST / Tempest Therapeutics, Inc.
|
|
|
|
|
|
|
|
CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
VYNE / VYNE Therapeutics Inc.
|
|
|
|
|
|
|
|
ZYME / Zymeworks Inc.
|
|
|
|
|
|
|
|
GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
US33830X1046 / Five Prime Therapeutics Inc
|
|
|
|
|
|
|
|
KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
CBAY / CymaBay Therapeutics, Inc.
|
|
|
|
|
|
|
|
MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
VRTX / Vertex Pharmaceuticals Incorporated Put
|
|
|
|
|
|
|
|
SVRA / Savara Inc.
|
|
|
|
|
|
|
|
SAGE / Sage Therapeutics, Inc. Put
|
|
|
|
|
|
|
|
ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
TGTX / TG Therapeutics, Inc.
|
|
|
|
|
|
|
|
BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
/ Array BioPharma, Inc.
|
|
|
|
|
|
|
|
SLDB / Solid Biosciences Inc. Call
|
|
|
|
|
|
|
|
PBYI / Puma Biotechnology, Inc.
|
|
|
|
|
|
|
|
AKBA / Akebia Therapeutics, Inc.
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock) Put
|
|
|
|
|
|
|
|
SAGE / Sage Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
NVAX / Novavax, Inc. Call
|
|
|
|
|
|
|
|
NVAX / Novavax, Inc. Put
|
|
|
|
|
|
|
|
PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
CTMX / CytomX Therapeutics, Inc.
|
|
|
|
|
|
|
|
VYGR / Voyager Therapeutics, Inc.
|
|
|
|
|
|
|
|